sever
acut
respiratori
syndrom
coronaviru
nucleocapsid
protein
sarscov
n
one
major
target
sar
vaccin
due
high
potenc
trigger
immun
respons
studi
identifi
novel
hlaa
restrict
epitop
lalllldrl
sarscov
nprotein
bioinformat
analysi
nprotein
peptid
show
high
bind
affin
toward
human
mhc
class
capabl
activ
cytotox
tcell
human
peripher
blood
mononuclear
cell
pbmc
applic
use
peptid
sequenc
singlechaintrim
sct
approach
produc
potenti
dna
vaccin
candid
investig
b
transgen
mice
cytotox
assay
clearli
show
tcell
obtain
vaccin
anim
abl
kill
nprotein
express
cell
cytotox
level
effector
cellstarget
cell
ratio
one
week
last
vaccin
significantli
higher
nprotein
peptid
previous
describ
novel
immunogen
nprotein
peptid
reveal
present
studi
provid
valuabl
inform
therapeut
sar
vaccin
design
sever
acut
respiratori
syndrom
sar
caus
novel
coronaviru
known
sarsassoci
coronaviru
sarscov
investig
sarscov
immun
garner
signific
attent
sinc
worldwid
outbreak
spread
countri
sarscov
envelop
positivestrand
rna
viru
encod
four
major
structur
protein
known
spike
glycoprotein
small
envelop
protein
e
integr
membran
glycoprotein
nucleocapsid
rnabind
protein
n
upon
viral
infect
viral
protein
express
within
infect
cell
degrad
cytosol
proteasom
peptid
gener
proteasom
transport
transport
associ
antigen
process
tap
lumen
endoplasm
reticulum
er
er
aminopeptidas
produc
matur
mhc
class
ipeptid
complex
trim
peptid
eight
nine
amino
acid
result
mhc
class
ipeptid
complex
express
surfac
profession
antigen
present
cell
dendrit
cell
play
import
role
activ
specif
cytotox
tcell
infect
cell
kill
hand
mhc
class
ipeptid
complex
express
viru
infect
cell
marker
kill
therefor
format
stabl
mhc
class
ipeptid
complex
critic
elicit
cytotox
tcell
respons
elimin
infect
cell
immunogen
peptid
sequenc
cytotox
tcell
determin
bind
affin
toward
human
mhc
class
molecul
avail
upon
proteasom
digest
parent
protein
subunit
vaccin
contain
hlaa
restrict
peptid
highli
effect
induct
strong
cytotox
tcell
respons
infecti
viru
among
four
structur
protein
sarscov
n
protein
major
target
vaccin
research
studi
due
potenc
trigger
immun
respons
protein
contain
amino
acid
involv
viral
entri
see
front
matter
elsevi
ltd
angiotensinconvert
enzym
receptor
host
cell
surfac
n
protein
contain
amino
acid
involv
viral
rna
packag
previou
studi
suggest
hlaa
restrict
sar
n
protein
peptid
trigger
specif
human
cytotox
tcell
respons
sar
vitro
present
studi
identifi
noval
hlaa
restrict
nprotein
peptid
lalllldrl
bind
affin
peptid
toward
human
mhc
class
molecul
compar
peptid
higher
peptid
previous
describ
moreov
order
stabliz
mhc
class
ipeptid
complex
antigen
present
sequenc
genet
link
cdna
human
microglobulin
domain
human
mhc
class
heavi
chain
form
singlechaintrim
sct
dna
vaccin
design
sct
approach
make
mhc
class
molecul
less
depend
chaperon
assist
peptid
load
henc
stabl
mhc
class
ipeptid
complex
antigen
present
produc
potenc
dna
vaccin
trigger
cytotox
tcell
respons
nprotein
express
cell
demonstr
b
transgen
mous
model
result
indic
sar
protein
peptid
good
vaccin
candid
sar
vaccin
develop
potenti
sar
nprotein
peptid
sequenc
human
mhc
class
bind
search
hla
peptid
bind
predict
program
syfpeithi
http
wwwsyfpeithid
seven
nineamino
acid
peptid
high
score
human
mhc
class
bind
alntpkdhi
lqlpqgttl
lalllldrl
llldrlnql
rlnqleski
gmsrigmev
illnkhid
synthes
solidphas
strategi
use
fmocbas
protocol
autom
peptid
synthes
crude
product
purifi
reversephas
prepar
high
perform
liquid
chromatographi
hplc
column
homogen
final
product
analyz
reversephas
hplc
puriti
peptid
store
dimethyl
sulfoxid
dmso
sigma
c
use
dna
sequenc
encod
nprotein
clone
express
vector
novagen
recombin
nprotein
express
escherichia
coli
system
ril
stratagen
follow
purif
ninta
hisbind
resin
novagen
protein
purif
puriti
quantiti
recombin
protein
analyz
sdspage
analysi
establish
nprotein
express
celllin
cytotox
assay
lung
tissu
b
transgen
mice
isol
minc
treat
collagenas
gibco
uml
min
tissu
sampl
seed
plate
cultur
week
fibroblast
collect
immort
transduct
recombin
retroviru
contain
sar
n
gene
gene
express
nprotein
lung
fibroblast
celllin
confirm
rtpcr
primer
n
sens
antisens
sens
atgtataaaactaaggg
antisens
celllin
name
b
posit
defici
tap
protein
endogen
antigen
present
cultur
accord
procedur
state
atcc
manual
determin
whether
select
nprotein
peptid
could
bind
human
mhc
class
molecul
puls
nprotein
peptid
gml
presenc
gml
human
microglobulin
sigma
h
peptid
puls
wash
twice
cold
pb
contain
fb
stain
mous
antihuman
antibodi
follow
goat
antimous
igg
fitc
antibodi
zyme
peptid
bound
fix
paraformaldehyd
sigma
subject
flow
cytometri
measur
rel
amount
mhc
class
ipeptid
complex
form
result
present
fluoresc
index
fi
calcul
mean
fluoresc
intens
mfi
cell
use
formula
fresh
human
hlaa
posit
peripher
blood
mononuclear
cell
pbmc
isol
ficollhypaqu
densiti
gradient
amersham
follow
enrich
tcell
human
microbead
mac
purifi
human
cell
subject
autolog
dendrit
cell
mediat
tcell
activ
vitro
brief
pbmc
seed
dish
h
nonadher
cell
remov
adher
monocyt
cultur
aimv
medium
invitrogen
supplement
human
ab
serum
uml
recombin
granulocytemacrophag
colonystimul
factor
gmcff
uml
recombin
human
interleukin
obtain
dendrit
cell
day
dendrit
cell
matur
addit
uml
recombin
human
interleukin
beta
uml
recombin
human
interleukin
ngml
recombin
human
tumor
necrosi
factoralpha
gml
prostaglandin
day
matur
dendrit
cell
load
select
nprotein
peptid
serum
free
medium
h
peptideload
dendrit
cell
cocultur
purifi
cell
presenc
uml
recombin
human
interleukin
ngml
recombin
human
interleukin
tcell
stimul
stimul
procedur
repeat
week
total
three
time
tcell
stimul
peptideload
dendrit
cell
conduct
activ
tcell
investig
elispot
assay
previous
describ
minor
modif
briefli
elispot
plate
multiscreenha
millipor
coat
antihuman
antibodi
gml
ebiosci
block
aimv
medium
contain
human
ab
serum
stimul
cell
ad
well
togeth
autolog
nprotein
load
bcell
incub
h
subsequ
plate
wash
follow
incub
gml
biotinyl
antibodi
ebiosci
c
anoth
h
wash
gml
streptavidinap
zyme
ad
incub
room
temperatur
min
spot
develop
ad
bcipnbt
solut
invitrogen
digit
record
elispot
plate
reader
servic
provid
beij
swan
tech
co
china
dna
sequenc
contain
human
microglobulin
chimer
mhc
heavi
chain
synthes
connect
mous
microglobulin
cdna
human
hlaa
cdna
hlaa
cdna
mous
b
domain
cdna
togeth
overlap
pcr
construct
mhk
gene
mous
microglobulin
h
human
hlaa
k
mous
b
use
two
templat
mk
b
sct
gene
gener
gift
prof
hansen
templat
mous
microglobulin
mous
b
domain
hhd
gene
provid
prof
lemonni
anoth
templat
human
hlaa
hlaa
dna
fragment
encod
select
nprotein
peptid
link
ntermin
mhk
gene
pcr
use
primer
correspond
dna
sequenc
region
gener
singlechaintrim
construct
singlechaintrim
dna
fragment
clone
agei
xhoi
site
invitrogen
construct
nprotein
peptideexpress
plasmid
vaccin
purpos
also
construct
control
plasmid
express
siinfekl
peptid
ovalbumin
bred
maintain
pathogenfre
condit
anim
care
center
hkust
hong
kong
dna
vaccin
deliv
week
old
transgen
mice
gene
gun
devic
previous
describ
minor
modif
briefli
cartridg
prepar
precipit
plasmid
dna
gold
particl
dissolv
spermidin
cacl
microcarrierdna
suspens
coat
plastic
tube
presenc
mgml
polyvinylpyrrolidon
sigma
coat
tube
cut
inch
cartridg
cartridg
contain
g
dna
dnacoat
gold
particl
deliv
shave
abdomin
region
mice
use
helio
gene
gun
biorad
discharg
pressur
psi
mous
administr
g
dna
per
inject
total
three
vaccin
within
interv
investig
cell
mediat
cytotox
respons
trigger
sctdna
vaccin
mice
sacrif
week
last
vaccin
splenocyt
obtain
cultur
imdm
medium
gibco
contain
gml
correspond
target
peptid
unit
peprotech
plate
nunc
c
day
tcell
cell
spleen
harvest
ficollhypaqu
amersham
densiti
gradient
centrifug
use
effector
cell
cytotox
assay
nprotein
transduc
b
cell
use
target
cell
cytotox
assay
effector
cell
target
cell
cocultur
ratio
h
incub
cultur
plate
centrifug
medium
collect
analysi
use
lactat
dehydrogenas
ldh
cytotox
detect
kit
roch
accord
procedur
state
manufactur
absorb
sampl
measur
elisa
reader
nm
nm
refer
wavelength
spontan
releas
ldh
target
cell
effector
cell
fulllength
amino
acid
sequenc
sar
nprotein
subject
bioinformat
analysi
search
hlaa
restrict
nineamino
acid
peptid
score
peptid
within
rang
amino
acid
sequenc
seven
peptid
select
high
score
list
middl
column
flu
peptid
gilgfvftl
use
posit
control
show
score
list
bottom
assess
incub
target
cell
absenc
effector
cell
vice
versa
maximum
releas
ldh
determin
incub
target
cell
triton
assay
medium
percentag
specif
cell
mediat
cytotox
determin
follow
equat
specif
cytotox
experiment
valu
effector
cell
spontan
releas
target
cell
spontan
releas
maximum
target
cell
releas
order
search
hlaa
restrict
peptid
sequenc
sar
nprotein
syfpetithi
program
employ
compar
bind
affin
nprotein
peptid
toward
human
mhc
class
molecul
bioinformat
analysi
seven
high
score
peptid
select
tabl
bind
activ
peptid
toward
human
mhc
class
molecul
investig
comparison
abil
stabil
empti
mhc
class
molecul
express
cell
surfac
presenc
microglobulin
presenc
stabl
mhc
class
ipeptid
complex
detect
antibodi
fac
result
clearli
show
among
seven
nprotein
peptid
display
highest
bind
affin
toward
human
mhc
class
result
fluoresc
intens
higher
posit
control
flu
peptid
gilgfvftl
fig
suggest
high
bind
affin
peptid
toward
human
mhc
class
tcell
immunogen
seven
select
peptid
test
abil
stimul
human
cell
isol
healthi
donor
pbmc
purifi
tcell
prime
three
time
autolog
matur
peptideload
dendrit
cell
level
tcell
activ
investig
releas
presenc
autolog
bcell
load
recombin
nprotein
target
peptid
nprotein
gener
present
target
cell
prime
tcell
could
specif
recogn
peptidemhc
complex
releas
elispot
result
show
tcell
prime
llldrlnql
lalllldrl
produc
highest
number
spot
six
seven
time
higher
found
irrelev
flu
peptid
prime
tcell
significantli
higher
select
nprotein
peptid
fig
result
tcell
stimul
assay
demonstr
novel
nprotein
peptid
reveal
present
studi
abl
trigger
specif
cytotox
tcell
respons
human
pbmc
four
immunogen
peptid
select
bind
assay
human
tcell
stimul
assay
test
potenc
trigger
immun
respons
sar
nprotein
express
cell
anim
model
facilit
antigen
present
dna
sequenc
target
peptid
genet
link
cdna
sequenc
mous
microglobulin
chimer
mhc
class
heavi
chain
domain
fig
peptid
translat
microglobulinspacehchain
complex
tcell
activ
coval
link
mhc
class
ipeptid
construct
link
mhc
molecul
least
less
access
exogen
peptid
normal
mhc
load
endogen
peptid
potent
stimul
cytotox
tcell
cytotox
tcell
respons
trigger
dna
vaccin
investig
activ
spleen
tcell
kill
target
cell
b
immort
primari
b
fibroblast
express
sar
ngene
fig
week
last
vaccin
cytotox
level
measur
amount
lactat
dehydrogenas
ldh
releas
target
cell
result
demonstr
dna
vaccin
encod
nprotein
peptid
trigger
highest
tcell
cytotox
toward
nprotein
express
cell
cytotox
level
respect
effector
cellstarget
cell
ratio
compar
cytotox
level
previous
describ
peptid
show
cytotox
similar
neg
control
use
irrelev
peptid
vaccin
fig
worldwid
outbreak
sar
caus
sever
econom
loss
develop
sar
vaccin
one
effect
way
prevent
outbreak
futur
ideal
vaccin
infecti
viru
abl
trigger
neutral
antibodi
product
cytotox
tcell
respons
play
critic
role
elimin
viru
infect
cell
control
viral
pathogensi
sarscov
infect
nprotein
report
highli
immunogen
yaxi
indic
percentag
cytotox
four
group
mice
vaccin
nprotein
peptid
plasmid
mice
vaccin
irrelev
plasmid
use
neg
control
cytotox
level
calcul
previous
describ
differ
cytotox
level
peptid
variou
effector
cell
target
cell
ratio
calcul
ttest
p
shown
n
vaccin
trigger
specif
tcell
respons
mice
howev
six
tcell
specif
epitop
nprotein
report
uptod
object
studi
identifi
immunogen
nprotein
peptid
serv
cytotox
tcell
epitop
sar
vaccin
peptid
sequenc
use
induc
cytotox
tcell
respons
present
endogen
peptid
epitop
proteasom
digest
high
bind
affin
toward
human
mhc
class
molecul
contrast
convent
method
screen
numer
amino
acid
sequenc
manual
synthet
peptid
librari
costli
time
consum
bioinformat
analysi
employ
search
immunogen
peptid
sequenc
sar
nprotein
although
effici
bioinformat
analysi
search
immunogen
peptid
high
discrep
result
could
also
obtain
differ
program
onlin
instanc
although
novel
immunogen
peptid
reveal
present
studi
third
potent
peptid
found
syfpetithi
program
rank
accord
hla
peptid
motif
search
provid
nation
institut
health
total
ignor
previou
studi
search
tcell
epitop
nprotein
investig
whether
peptid
predict
comput
program
high
bind
affin
human
mhc
bind
assay
conduc
base
bind
affin
peptid
empti
mhc
class
molecul
cell
surfac
stabil
mhc
class
ipeptid
complex
form
result
clearli
show
novel
peptid
identifi
present
studi
high
bind
affin
toward
human
mhc
class
molecul
compar
peptid
significantli
higher
peptid
previous
describ
previou
studi
suggest
peptid
sequenc
high
bind
affin
abl
trigger
tcell
respons
peptid
sequenc
gener
endogen
process
proteasom
system
instanc
although
peptid
high
affin
toward
molecul
abl
elicit
cytotox
tcell
respons
sinc
peptid
process
natur
parent
protein
proteasom
address
question
concern
intracellular
protein
process
tcell
activ
assay
nprotein
load
bcell
abl
crosspres
protein
antigen
proteasom
system
preform
tcell
activ
assay
demonstr
nprotein
load
bcell
use
target
cell
prime
tcell
induc
product
level
produc
compar
peptid
significantli
higher
peptid
previous
describ
consist
result
obtain
bind
assay
although
studi
previous
map
three
hlaa
restrict
nprotein
peptid
vaccin
transgen
mice
vaccin
potenc
address
present
studi
potenc
novel
peptid
togeth
three
previous
describ
peptid
vaccin
investig
transgen
mous
model
express
human
contrast
convent
method
use
expens
synthet
peptid
inject
infeas
practic
use
larg
vaccin
program
sct
display
dna
vaccin
mechan
employ
dna
vaccin
much
less
costli
compar
synthet
peptid
coupl
sct
display
system
immunogen
peptid
translat
togeth
microglobulin
mhc
class
heavi
chain
molecul
complex
translat
whole
coval
link
mhc
class
ipeptid
complex
transfer
er
cell
surfac
antigen
present
high
stabil
coval
link
mhc
class
ipeptid
complex
produc
sct
system
exclud
compet
peptid
potent
stimul
tcell
thu
elimin
uncertainti
antigen
process
profession
antigen
present
cell
cytotox
tcell
prime
directli
ensur
peptid
encod
vaccin
present
vaccin
studi
dna
vaccin
inject
transgen
mice
vaccin
cytotox
assay
demonstr
vaccin
peptid
abl
trigger
cytotox
tcell
respons
nprotein
express
cell
earli
week
last
vaccin
even
absenc
adjuv
compar
result
obtain
cytotox
assay
among
test
peptid
indic
peptid
repres
one
potent
amino
acid
sequenc
nprotein
abl
trigger
cytotox
tcell
respons
interestingli
report
immunogen
tcell
epitop
nprotein
includ
reveal
present
studi
mostli
cluster
amino
acid
residu
therefor
interest
investig
whether
vaccin
compos
amino
acid
peptid
coupl
known
sar
bcell
epitop
previous
describ
suffici
trigger
protect
immun
respons
sarscov
human
summari
identifi
novel
specif
sarscov
n
protein
epitop
lalllldrl
activ
cytotox
tcell
vitro
use
sct
system
suffici
elicit
cytotox
tcell
respons
nprotein
express
cell
b
transgen
mous
model
find
novel
cytotox
tcell
epitop
present
studi
provid
worth
inform
sar
vaccin
design
may
contribut
sar
control
program
futur
